默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRK 默沙东

盘前交易 07-22 04:57:28 EDT

125.77

+1.52

+1.22%

盘前125.96

+0.19+0.15%

04:30 EDT

最高126.99	最低125.18	成交量683.66万
今开125.30	昨收124.25	日振幅1.46%
总市值3,186亿	流通市值3,180亿	总股本25.33亿
成交额8.61亿	换手率0.27%	流通股本25.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRK","market":"US","secType":"STK","nameCN":"默沙东","latestPrice":125.77,"timestamp":1721419200000,"preClose":124.25,"halted":0,"volume":6836648,"hourTrading":{"tag":"盘前","latestPrice":125.96,"preClose":125.77,"latestTime":"04:30 EDT","volume":5,"amount":629.8,"timestamp":1721637059570},"delay":0,"floatShares":2528326785,"shares":2532806307,"eps":0.89667,"marketStatus":"盘前交易","marketStatusCode":1,"change":1.52,"latestTime":"07-22 04:57:28 EDT","open":125.3,"high":126.99,"low":125.18,"amount":860833114.5960001,"amplitude":0.014567,"askPrice":126,"askSize":111,"bidPrice":125.36,"bidSize":6,"shortable":3,"etf":0,"ttmEps":0.89667,"exchange":"NYSE","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"listingDate":-745790400000,"adjPreClose":125.77,"adrRate":0,"dividendRate":0.023535,"preHourTrading":{"tag":"盘前","latestPrice":125.96,"preClose":125.77,"latestTime":"04:30 EDT","volume":5,"amount":629.8,"timestamp":1721637059570},"postHourTrading":{"tag":"盘后","latestPrice":125.15,"preClose":125.77,"latestTime":"19:41 EDT","volume":321011,"amount":40365308.3798,"timestamp":1721432509925},"volumeRatio":0.8721251337950342,"impliedVol":0.2712,"impliedVolPercentile":0.98},"requestUrl":"/m/hq/s/MRK","defaultTab":"news","newsList":[{"id":"2453975536","title":"投资并购为全球科技创新赋能 Jolt Capital与默克集团达成最终协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2453975536","media":"全景网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453975536?lang=zh_cn&edition=full","pubTime":"2024-07-22 15:47","pubTimestamp":1721634425,"startTime":"0","endTime":"0","summary":"近日，Jolt Capital宣布与默克集团达成重要并购协议，正式出售Jolt Capital IV投资组合中unity-SC公司股份。自Unity-SC成立以来，Jolt Capital一直在关注它的发展，并在2016年和2018年直接参与了整合收购。2022年，Jolt Capital与Supernova Invest以及通过法国科技主权计划的法国政府共同领导了追加融资，使公司能够提升其作为半导体计量关键玩家的地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072215554095e78b69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072215554095e78b69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0058720904.USD","LU1037948541.HKD","IE00BBT3K403.USD","LU0965508806.USD","IE00B4R5TH58.HKD","LU1934455194.USD","BK4534","IE00B1BXHZ80.USD","LU1989771016.USD","BK4585","LU1066051811.HKD","LU0238689110.USD","LU0861579265.USD","LU1037948897.HKD","IE00BJT1NW94.SGD","LU0965509283.SGD","LU0234572021.USD","IE00B2B36J28.USD","LU0208291251.USD","LU0070302665.USD","LU1023059063.AUD","BK4588","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU0265550946.USD","LU1116320737.USD","IE00BLSP4452.SGD","LU1066053197.SGD","BK4550","LU1057294990.SGD","LU1941712348.USD","IE00BSNM7G36.USD","LU0965509010.AUD","LU0985320562.USD","MRK","IE0009355771.USD","LU1941712264.USD","LU1116320901.HKD","LU0320765489.SGD","LU0266013472.USD","LU1291159041.SGD","LU1934455277.USD","LU1093756168.USD","LU1917777945.USD","IE00BLSP4239.USD","LU1974910355.USD","LU0965509101.SGD","LU1585245621.USD","LU1430594728.SGD","IE00BN8TJ469.HKD"],"gpt_icon":0},{"id":"2452268138","title":"年薪高达750万！百济神州女高管辞职，此前两年每年涨薪超百万，默沙东高管接任","url":"https://stock-news.laohu8.com/highlight/detail?id=2452268138","media":"市场资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452268138?lang=zh_cn&edition=full","pubTime":"2024-07-20 17:31","pubTimestamp":1721467860,"startTime":"0","endTime":"0","summary":"按7月19日百济神州128.48元的收盘价计算，仅王爱军直接持有的64701股普通股，价值达到了831.28万元。股权价值加上三年的税前报酬总额合计超2700万元。　　7月18日晚间，创新药、生物科技公司百济神州发布公告称，高级管理人员AijunWang（王爱军）于近日向公司提出离职申请，其将于2024年7月19日正式辞任公司首席财务官。　　百济神州表示，Rosenberg在公司变革性的一年加入。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/wm/2024-07-20/doc-inceurty1031361.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2024-07-20/doc-inceurty1031361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1934455863.HKD","BK4516","BK1588","BK4534","BK4559","LU0307460666.USD","LU1066051225.USD","IE000M9KFDE8.USD","LU1974910355.USD","LU1116320737.USD","BK1161","LU2328871848.SGD","LU1093756325.SGD","06160","LU0320765489.SGD","LU0211331839.USD","LU1066051498.USD","IE00B4R5TH58.HKD","MRK","IE0009355771.USD","BK4533","BK0239","LU0985320562.USD","LU0265550946.USD","BK4139","LU0588546209.SGD","LU1430594728.SGD","BK4535","LU1116320901.HKD","LU0265550359.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","LU1066053197.SGD","LU1941712264.USD","LU0122379950.USD","LU0861579265.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BK4548","BK1500","IE0002141913.USD","LU1917777945.USD","BK4585","LU1989772840.SGD","BK4550","BK4007","BGNE","688235","BK4588"],"gpt_icon":0},{"id":"2452798394","title":"默沙东上涨1.24%，报125.785美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452798394","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452798394?lang=zh_cn&edition=full","pubTime":"2024-07-19 21:34","pubTimestamp":1721396060,"startTime":"0","endTime":"0","summary":"7月19日，默沙东(MRK)开盘上涨1.24%，截至21:34，报125.785美元/股，成交8382.59万美元。财务数据显示，截至2024年03月31日，默沙东收入总额157.75亿美元，同比增长8.89%；归母净利润47.62亿美元，同比增长68.81%。大事提醒：7月30日，默沙东将于(美东)盘前披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/19213441687392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1941712264.USD","LU1057294990.SGD","BK4534","LU1989772840.SGD","BK4533","IE00B4R5TH58.HKD","IE00BBT3K403.USD","IE00BJJMRZ35.SGD","LU1066053197.SGD","LU1093756325.SGD","LU0208291251.USD","LU0965509283.SGD","LU1989771016.USD","LU1116320737.USD","LU1066051811.HKD","IE00BJT1NW94.SGD","LU1023059063.AUD","LU1116320901.HKD","LU0211331839.USD","IE00BLSP4239.USD","LU0985320562.USD","LU1585245621.USD","LU0965509010.AUD","IE00B2B36J28.USD","LU0861579265.USD","LU1917777945.USD","IE000M9KFDE8.USD","LU0122379950.USD","LU1061106388.HKD","LU1974910355.USD","BK4007","IE0009355771.USD","LU1066051225.USD","BK4585","LU1093756168.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0320765489.SGD","LU0265550946.USD","LU1066051498.USD","LU1934455863.HKD","LU0965508806.USD","LU0289739699.SGD","LU0058720904.USD","LU0070302665.USD","MRK","BK4588","LU1430594728.SGD","LU0265550359.USD","IE00B1BXHZ80.USD"],"gpt_icon":0},{"id":"2452782584","title":"年薪高达750万元！市值1700亿巨头53岁女高管辞职：寻求外部机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2452782584","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452782584?lang=zh_cn&edition=full","pubTime":"2024-07-19 17:32","pubTimestamp":1721381548,"startTime":"0","endTime":"0","summary":"750万年薪的高管也会辞职，你敢信？  7月18日晚间，创新药、生物科技公司百济神州（SH688235）发布公告称，高级管理人员Aijun(Julia)Wang（王爱军）女士于近日向公司提出离职申请，其将于2024年7月19日正式辞任公司首席财务官。辞任首席财务官后，王爱军将以高级顾问身份继续为公司提供服务以协助首席财务官的过渡，服务期...","market":"hk","thumbnail":"https://inews.gtimg.com/news_ls/Or3QNKA9XOQClAivIUTxRgehk_BH6l6eBeTsSvKGj4m-EAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/news_ls/Or3QNKA9XOQClAivIUTxRgehk_BH6l6eBeTsSvKGj4m-EAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240719A07BVO00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240719A07BVO00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["IE0002141913.USD","LU1093756325.SGD","LU2328871848.SGD","IE00BN8TJ469.HKD","IE0009355771.USD","BK1500","LU1066051225.USD","BK4559","LU0266013472.USD","BK1161","BK4007","BK4588","BK1583","BK4585","LU0238689110.USD","LU1066053197.SGD","IE00B2B36J28.USD","LU1934455277.USD","LU1941712264.USD","LU1917777945.USD","LU0211331839.USD","IE00B4R5TH58.HKD","LU1116320901.HKD","LU0985320562.USD","LU1430594728.SGD","LU0265550946.USD","BGNE","LU0588546209.SGD","LU1969619763.USD","LU0965508806.USD","IE00BFTCPJ56.SGD","LU0861579265.USD","06160","LU0965509010.AUD","IE00BSNM7G36.USD","LU0070302665.USD","BK4550","LU0320765489.SGD","LU1061106388.HKD","BK1588","BK4505","LU0307460666.USD","LU1934455863.HKD","LU1934455194.USD","LU0965509101.SGD","MRK","LU1974910355.USD","BK4139","BK4516","LU1116320737.USD"],"gpt_icon":0},{"id":"2452123264","title":"肿瘤市场大洗牌，谁是新王","url":"https://stock-news.laohu8.com/highlight/detail?id=2452123264","media":"蓝鲸财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452123264?lang=zh_cn&edition=full","pubTime":"2024-07-19 14:36","pubTimestamp":1721371003,"startTime":"0","endTime":"0","summary":"根据Evaluate发布最新报告，2030年全球药企的总销售额将超过1.7万亿美元。当然，尽管如此，肿瘤仍然是最有价值、最吸金的治疗领域，预计2030年所有产品的销售额将超过3700亿美元。巨大的市场，纷争自然不止。Evaluate预计，2030年强生将在达雷妥尤单抗的大力支持，成为肿瘤领域第一，紧随其后的是阿斯利康、默沙东、罗氏和第一三共。无论Evaluate预测中下一个肿瘤霸主强生还是昔日霸主罗氏，都是靠血液瘤重磅炸弹为基础，一步步奠定自己的地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/235396","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0345770993.USD","LU2133065610.SGD","SG9999002224.SGD","LU1162221912.USD","IE00B2B36J28.USD","LU1221951046.USD","IE00B4R5TH58.HKD","LU1941712348.USD","LU0234572021.USD","JNJ","BK4504","LU0965508806.USD","LU1037948897.HKD","LU2347655156.SGD","BK4592","LU1934455194.USD","LU1974910355.USD","LU0889566641.SGD","LU2602419157.SGD","LU1244550494.USD","LU0345770308.USD","LU1941712264.USD","LU0238689110.USD","LU0795875086.SGD","BK4588","BK4581","LU1032466523.USD","LU1430594728.SGD","LU0965509010.AUD","LU1059921491.USD","IE00BN8TJ469.HKD","MRK","LU1934455277.USD","LU1929549753.HKD","LU0965509101.SGD","LU0266013472.USD","FL","IE00B19Z3581.USD","LU1221951129.SGD","LU1291159041.SGD","LU1196500208.SGD","LU0640476718.USD","LU1032955483.USD","LU0320765489.SGD","LU0265550946.USD","LU0985320562.USD","LU0070302665.USD","LU1116320901.HKD","IE00BSNM7G36.USD","LU0861579265.USD"],"gpt_icon":0},{"id":"2452368419","title":"百济神州CFO辞职，此前每年涨薪超百万！继任者来自默沙东","url":"https://stock-news.laohu8.com/highlight/detail?id=2452368419","media":"中新经纬","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452368419?lang=zh_cn&edition=full","pubTime":"2024-07-19 13:36","pubTimestamp":1721367379,"startTime":"0","endTime":"0","summary":"中新经纬7月19日电 (王玉玲)18日晚间，生物科技公司百济神州发布公告称，高级管理人员Aijun(Julia)Wang(王爱军)于近日提出离职申请以寻求外部发展机会，将于2024年7月19日正式辞任首席财务官(CFO)。　　百济神州表示，王爱军辞任的决定并非由于其与公司在运营、政策或实践方面有任何分歧，其辞任不会对公司的日常运营造成不...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/O3Ne3Clda66QwqiSl8VPCmCrLFWn7cJ77QP3sfoNnfNpAAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/O3Ne3Clda66QwqiSl8VPCmCrLFWn7cJ77QP3sfoNnfNpAAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240719A04J9O00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240719A04J9O00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["LU0266013472.USD","LU1969619763.USD","LU0965509010.AUD","LU1430594728.SGD","LU0070302665.USD","BK4559","LU1974910355.USD","BK1161","LU1116320901.HKD","BGNE","LU0861579265.USD","BK4588","IE00B4R5TH58.HKD","LU1934455277.USD","LU0265550946.USD","LU1917777945.USD","LU0238689110.USD","LU0320765489.SGD","BK4585","IE00BLSP4452.SGD","IE00BN8TJ469.HKD","BK4550","IE00B2B36J28.USD","LU1037948897.HKD","LU1116320737.USD","IE00BFTCPJ56.SGD","LU2328871848.SGD","BK1588","BK4505","LU0985320562.USD","BK4526","LU0307460666.USD","LU1934455194.USD","BK4516","LU1941712264.USD","IE0009355771.USD","LU1037948541.HKD","LU1066053197.SGD","MRK","BK1583","06160","BK4139","LU0234572021.USD","BK1500","LU0588546209.SGD","LU0965508806.USD","LU1291159041.SGD","LU0965509101.SGD","IE00BSNM7G36.USD","LU1941712348.USD"],"gpt_icon":0},{"id":"2452485178","title":"百济神州CFO王爱军离职：任职3年 前默沙东高管接任","url":"https://stock-news.laohu8.com/highlight/detail?id=2452485178","media":"雷递网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452485178?lang=zh_cn&edition=full","pubTime":"2024-07-18 20:37","pubTimestamp":1721306261,"startTime":"0","endTime":"0","summary":"雷递网 乐天 7月18日百济神州有限公司日前发布公告，宣布公司高级管理人员Aijun Wang（王爱军）女士于近日向公司提出离职申请以寻求外部发展机会，其将于2024年7月19日正式辞任公司首席财务官。百济神州称，王爱军女士辞任的决定并非由于其与公司在运营、政策或实践方面有任何分歧，其辞任不会对公司的日常运营造成不利影响。这意味着时隔3年后，王爱军女士卸任了CFO职务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182037529f64c5fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407182037529f64c5fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","06160","MRK","BGNE","LU0307460666.USD","BK1583","BK1588","BK1500","BK1161","LU1969619763.USD","LU0588546209.SGD","688235"],"gpt_icon":0},{"id":"2452591013","title":"默沙东下跌1.21%，报126.575美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2452591013","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452591013?lang=zh_cn&edition=full","pubTime":"2024-07-17 00:48","pubTimestamp":1721148496,"startTime":"0","endTime":"0","summary":"7月17日，默沙东(MRK)盘中下跌1.21%，截至00:48，报126.575美元/股，成交2.59亿美元。财务数据显示，截至2024年03月31日，默沙东收入总额157.75亿美元，同比增长8.89%；归母净利润47.62亿美元，同比增长68.81%。大事提醒：7月30日，默沙东将于(美东)盘前披露2024财年中报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/17004841608857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["IE00BSNM7G36.USD","LU1989772840.SGD","IE00B2B36J28.USD","IE00BBT3K403.USD","LU1941712264.USD","BK4533","LU0238689110.USD","IE00B4R5TH58.HKD","LU1093756168.USD","IE00BJJMRZ35.SGD","LU1974910355.USD","LU1934455277.USD","BK4534","IE0002141913.USD","LU1066051811.HKD","LU0965509010.AUD","BK4588","LU1989771016.USD","LU0265550946.USD","LU0058720904.USD","IE00BN8TJ469.HKD","LU0320765489.SGD","LU0211331839.USD","LU1066051225.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU1934455194.USD","MRK","LU0985320562.USD","LU1093756325.SGD","LU1430594728.SGD","LU0265550359.USD","LU1934455863.HKD","LU1917777945.USD","BK4585","LU0122379950.USD","LU1291159041.SGD","LU1061106388.HKD","LU1066051498.USD","LU0070302665.USD","LU0965508806.USD","LU1066053197.SGD","LU0266013472.USD","LU0965509101.SGD","IE000M9KFDE8.USD","IE00BJT1NW94.SGD","LU0861579265.USD","IE00B1BXHZ80.USD","LU1116320737.USD","LU1116320901.HKD"],"gpt_icon":0},{"id":"2451933439","title":"1.35亿美元！与默沙东“分手”后，这家NK细胞疗法公司再冲IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2451933439","media":"医药魔方Pro","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451933439?lang=zh_cn&edition=full","pubTime":"2024-07-16 19:15","pubTimestamp":1721128521,"startTime":"0","endTime":"0","summary":"同样是在2021年，默沙东与Artiva签订了总额超18亿美元的全球独家合作和许可协议，前者将利用后者的现货型同种异体NK细胞制造平台及专有的CAR-NK技术开发针对实体瘤相关抗原的新型CAR-NK细胞疗法。而根据Artiva近期一份公开文件显示，与默沙东的合作已经于2023年10月结束。与默沙东的合作破灭之后，Artiva近日宣布将寻求在美股上市，以支持核心管线AlloNK的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161936389f55d586&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161936389f55d586&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1037948897.HKD","IE0002141913.USD","IE00B1BXHZ80.USD","LU1917777945.USD","LU1974910355.USD","LU1037948541.HKD","LU1585245621.USD","LU1066051225.USD","LU0070302665.USD","LU0265550359.USD","LU0265550946.USD","LU1941712264.USD","BK4534","LU1934455194.USD","LU0238689110.USD","LU1057294990.SGD","IE00BJJMRZ35.SGD","BK4585","MRK","IE00BLSP4239.USD","LU0965508806.USD","LU0965509283.SGD","LU1066053197.SGD","LU1941712348.USD","LU0266013472.USD","BK4588","LU0058720904.USD","BK4533","LU0234572021.USD","LU1116320737.USD","LU1934455863.HKD","IE00BSNM7G36.USD","LU0211331839.USD","LU0965509010.AUD","LU1989771016.USD","LU0985320562.USD","LU0320765489.SGD","LU1116320901.HKD","LU0965509101.SGD","IE00B2B36J28.USD","BK4559","LU1066051811.HKD","IE0009355771.USD","LU1989772840.SGD","LU0289739699.SGD","IE00BLSP4452.SGD","IE00BJT1NW94.SGD","LU1934455277.USD","IE00BN8TJ469.HKD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2451955251","title":"诺和诺德支持瑞士生物技术公司 Asceneuron 完成 1 亿美元融资","url":"https://stock-news.laohu8.com/highlight/detail?id=2451955251","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451955251?lang=zh_cn&edition=full","pubTime":"2024-07-16 15:00","pubTimestamp":1721113208,"startTime":"0","endTime":"0","summary":" Maggie Fick    路透伦敦7月16日 - 瑞士生物技术公司Asceneuron周二表示，它已从包括Wegovy生产商诺和诺德公司控股股东在内的投资者那里筹集到1亿美元，用于资助其阿尔茨海默病药物的临床开发。Asceneuron公司的领先实验药物ASN51属于一类新药，被称为O-GlcNA酶 抑制剂。一周前，诺和诺德控股公司牵头为英国生物技术公司Myricx Pharma单独进行了一轮9000万英镑，以推进其实验性癌症药物的研发。诺和诺德控股公司的投资资金也在不断增加。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985320562.USD","LU0208291251.USD","LU0154236417.USD","LU0672654240.SGD","LU0965509101.SGD","LU0070302665.USD","IE00B19Z9Z06.USD","LU0266013472.USD","IE00B894F039.SGD","IE00BZ1G4Q59.USD","LU1267930730.SGD","LU0965509010.AUD","LU1037948897.HKD","LU1585245621.USD","LU1974910355.USD","IE00BK4W5L77.USD","IE00BLSP4239.USD","LU0965508806.USD","MRK","BK4588","LU1430594728.SGD","IE00BN8TJ469.HKD","LU0965509283.SGD","IE00B4R5TH58.HKD","LU0238689110.USD","IE00BLSP4452.SGD","NVO","LU0456855351.SGD","LU1941712348.USD","BIIB","LU0320765059.SGD","LU0471298777.SGD","LU1037948541.HKD","LU0417517546.SGD","LU1941712264.USD","LU1023059063.AUD","LU0289739699.SGD","LU1934455277.USD","LU0234572021.USD","LU1934455194.USD","BK4581","LU0234570918.USD","LU0265550946.USD","IE00BSNM7G36.USD","IE00B2B36J28.USD","LLY","LU0256863902.USD","LU1291159041.SGD","IE00BK4W5M84.HKD","BK4139"],"gpt_icon":0},{"id":"2451568441","title":"默沙东下跌1.23%，报127.38美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451568441","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451568441?lang=zh_cn&edition=full","pubTime":"2024-07-13 03:57","pubTimestamp":1720814256,"startTime":"0","endTime":"0","summary":"7月13日，默沙东(MRK)盘中下跌1.23%，截至03:57，报127.38美元/股，成交4.96亿美元。财务数据显示，截至2024年03月31日，默沙东收入总额157.75亿美元，同比增长8.89%；归母净利润47.62亿美元，同比增长68.81%。大事提醒：7月30日，默沙东将于(美东)盘前披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/13035741553694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0058720904.USD","LU0985320562.USD","IE00BSNM7G36.USD","LU1066051811.HKD","IE00BJT1NW94.SGD","LU1917777945.USD","LU1989771016.USD","LU0070302665.USD","LU0266013472.USD","LU0861579265.USD","LU0965509010.AUD","IE0009355771.USD","LU0265550359.USD","LU1066053197.SGD","LU1066051498.USD","LU1934455194.USD","BK4559","BK4533","BK4585","IE00B2B36J28.USD","LU1430594728.SGD","MRK","IE00BFTCPJ56.SGD","LU0122379950.USD","IE00BJJMRZ35.SGD","LU0965508806.USD","LU1093756325.SGD","LU1066051225.USD","LU0265550946.USD","BK4007","BK4550","IE000M9KFDE8.USD","IE0002141913.USD","LU0238689110.USD","IE00BN8TJ469.HKD","IE00B4R5TH58.HKD","LU1116320901.HKD","LU1116320737.USD","LU1974910355.USD","LU0211331839.USD","BK4516","LU1061106388.HKD","LU1934455277.USD","LU1941712264.USD","LU0320765489.SGD","LU1934455863.HKD","BK4534","LU1989772840.SGD","IE00B1BXHZ80.USD","IE00BBT3K403.USD"],"gpt_icon":0},{"id":"2450854285","title":"TIGIT靶点命途多舛！罗氏再受挫，诺华、默沙东刹车，吉利德、GSK前景几何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2450854285","media":"医药经济报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450854285?lang=zh_cn&edition=full","pubTime":"2024-07-12 18:56","pubTimestamp":1720781795,"startTime":"0","endTime":"0","summary":"作为肿瘤治疗领域的潜力靶点，TIGIT靶点药物命途多舛的研发进程，产业始终给予高度关注。这是全球首个TIGIT III期临床失败案例。2021年底，TIGIT靶点迎来商业合作热潮。短短一个月内，3个重大的制药行业合作案例将TIGIT靶点推向了前所未有的热度。然而，随着临床试验的深入，TIGIT靶点药物的实际疗效和安全性受到更严格的检验。尽管如此，罗氏并未完全放弃对TIGIT靶点的探索。诺华、默沙东“撤退”吉利德、GSK前景几何？","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121903089f3b5288&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121903089f3b5288&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1023059063.AUD","BK4533","IE00BJT1NW94.SGD","LU1839511570.USD","BK4583","LU1037948541.HKD","LU1057294990.SGD","LU1061106388.HKD","LU1934455863.HKD","LU0320765992.SGD","IE00BLSP4239.USD","BK4007","BK4566","LU1989772840.SGD","BK4578","LU1571399168.USD","LU1066053197.SGD","BK4550","LU2468319806.SGD","LU1066051225.USD","IE00B1BXHZ80.USD","GSK.UK","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU0211331839.USD","BK4585","LU0058720904.USD","MRK","IE000M9KFDE8.USD","BK4588","LU0289739699.SGD","LU1066051498.USD","IE0002141913.USD","LU1585245621.USD","BK4568","LU1066051811.HKD","BK4534","BK4139","LU1093756168.USD","BK4516","IE00BBT3K403.USD","GILD","BK4559","LU0208291251.USD","LU0265550359.USD","LU1989771016.USD","NVS","GSK","LU0965509283.SGD","LU0122379950.USD"],"gpt_icon":0},{"id":"2450017323","title":"BUZZ-澳大利亚 Immutep 公司因癌症试验结果良好而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2450017323","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450017323?lang=zh_cn&edition=full","pubTime":"2024-07-12 11:02","pubTimestamp":1720753343,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    7月12日 - ** Immutep  股价上涨27.1%至0.375澳元，创6月27日以来新高** 股价创下自2023年5月18日以来的最大盘中涨幅** 生物技术公司称， (link)，评估 eftilagimod alfa(efti) 与默克公司  的抗PD-1疗法KEYTRUDA联用的TACTI-003 IIb期试验B组获得积极结果** 该试验用于治疗头颈部鳞状细胞癌（一种皮肤癌）。** 约1300万股易手，而30天平均成交量为660万股** 截至上次收盘，该股今年已下跌近 14","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMM.AU","LU1430594728.SGD","IE00BLSP4239.USD","IE00BSNM7G36.USD","LU0266013472.USD","IE00BFTCPJ56.SGD","LU1974910355.USD","BK4550","BK4585","IE0002141913.USD","LU1093756325.SGD","LU0265550946.USD","LU1066051225.USD","BK4588","LU1066053197.SGD","BK7067","LU0861579265.USD","MRK","IE0009355771.USD","IE00BN8TJ469.HKD","LU0320765489.SGD","LU0234572021.USD","LU1917777945.USD","LU1116320737.USD","LU0965508806.USD","LU1941712264.USD","LU1037948897.HKD","LU0238689110.USD","LU1291159041.SGD","LU1023059063.AUD","LU1934455194.USD","LU1585245621.USD","LU1941712348.USD","LU0965509101.SGD","IE00B2B36J28.USD","LU1116320901.HKD","IE00B4R5TH58.HKD","LU0985320562.USD","LU1057294990.SGD","BK7508","LU0965509283.SGD","IE00BLSP4452.SGD","LU0965509010.AUD","LU1934455277.USD","LU1037948541.HKD","LU0208291251.USD","BK4516","LU0070302665.USD","BK4559","LU0289739699.SGD"],"gpt_icon":0},{"id":"2450839044","title":"默沙东上涨1.23%，报128.86美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450839044","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450839044?lang=zh_cn&edition=full","pubTime":"2024-07-12 03:57","pubTimestamp":1720727831,"startTime":"0","endTime":"0","summary":"7月12日，默沙东(MRK)盘中上涨1.23%，截至03:57，报128.86美元/股，成交5.38亿美元。财务数据显示，截至2024年03月31日，默沙东收入总额157.75亿美元，同比增长8.89%；归母净利润47.62亿美元，同比增长68.81%。大事提醒：7月30日，默沙东将于(美东)盘前披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/12035741527775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1093756168.USD","MRK","BK4516","LU0266013472.USD","LU0965509283.SGD","LU0238689110.USD","IE00B4R5TH58.HKD","BK4007","LU1037948541.HKD","BK4559","LU1057294990.SGD","LU1430594728.SGD","IE0009355771.USD","LU1934455277.USD","IE00B2B36J28.USD","LU1023059063.AUD","IE00B1BXHZ80.USD","LU0965508806.USD","LU0985320562.USD","IE00BBT3K403.USD","LU1037948897.HKD","IE00BLSP4239.USD","LU0965509010.AUD","LU0320765489.SGD","LU0208291251.USD","LU1066051811.HKD","LU0861579265.USD","LU0265550946.USD","LU1116320737.USD","LU1917777945.USD","LU1066053197.SGD","IE00BLSP4452.SGD","IE00BSNM7G36.USD","LU1585245621.USD","LU0965509101.SGD","BK4550","LU0234572021.USD","LU1116320901.HKD","LU1291159041.SGD","BK4588","LU0289739699.SGD","IE00BN8TJ469.HKD","LU1974910355.USD","LU1934455194.USD","LU1941712264.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU1941712348.USD","BK4585","LU0070302665.USD"],"gpt_icon":0},{"id":"2450351438","title":"牵手默克入账近5亿 和誉医药扭亏为盈 上半年净赚超2亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2450351438","media":"时代财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450351438?lang=zh_cn&edition=full","pubTime":"2024-07-11 20:07","pubTimestamp":1720699658,"startTime":"0","endTime":"0","summary":"又一港股18A创新药企扭亏为盈。7月10号晚间，和誉医药（02256.HK）发布正面盈利预告，公司预期今年上半年度总收入约为4.97亿元，实现扭亏为盈，上年同期为亏损2.09亿元；预期今年上半年录得期内溢利约2.0亿~2.2亿元，首次实现半年度盈利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202407113128806492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1066051498.USD","IE00BSNM7G36.USD","BK1515","LU0265550946.USD","IE0009355771.USD","LU0070302665.USD","LU1093756325.SGD","LU0965508806.USD","09939","IE00BJJMRZ35.SGD","LU2488822045.USD","LU0985320562.USD","BK4534","LU0965509010.AUD","02256","LU1061106388.HKD","LU0266013472.USD","LU0238689110.USD","LU0965509101.SGD","LU1291159041.SGD","LU1430594728.SGD","BK4559","IE00B2B36J28.USD","BK4550","IE00BFTCPJ56.SGD","LU1989772840.SGD","LU0211331839.USD","LU1974910355.USD","BK1161","LU1941712264.USD","LU1116320901.HKD","IE0002141913.USD","LU1934455194.USD","LU0234572021.USD","BK4533","IE00B4R5TH58.HKD","IE00BN8TJ469.HKD","LU1066051225.USD","BK4007","LU0861579265.USD","LU1116320737.USD","LU1066053197.SGD","LU0320765489.SGD","IE000M9KFDE8.USD","LU1917777945.USD","LU1934455277.USD","LU1934455863.HKD","BK4585","MRK","BK4516"],"gpt_icon":0},{"id":"2450355380","title":"百亿口服降糖药筚路蓝缕！信立泰、海思科新药获批，默沙东、礼来等压力山大","url":"https://stock-news.laohu8.com/highlight/detail?id=2450355380","media":"医药经济报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450355380?lang=zh_cn&edition=full","pubTime":"2024-07-11 18:58","pubTimestamp":1720695506,"startTime":"0","endTime":"0","summary":"国内新型降糖药物市场正成为群雄纷争的战略要地。无独有偶，就在信立泰药业的福格列汀获批上市前不久，6月24日，海思科自主研发的超长效DPP-4抑制剂考格列汀也获批上市，适用于改善成人2型糖尿病患者的血糖控制。目前，国内已有9款DPP-4 抑制剂创新药获批上市，但近70%来自跨国药企。近期，国产DPP-4抑制剂市场迎来了新的活力。目前，西格列汀片中国市场已经有14家企业获批仿制，均视同通过一致性评价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071119283695a5dacd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071119283695a5dacd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109391861.USD","LU0672654240.SGD","LU0266013472.USD","LU1093756168.USD","IE00BK4W5L77.USD","BK4534","IE00BLSP4239.USD","LU0070302665.USD","LU0094547139.USD","IE000M9KFDE8.USD","LU1066051498.USD","IE00BK4W5M84.HKD","IE00BBT3K403.USD","LU0061475181.USD","LU0708995401.HKD","LU1934455277.USD","BK4533","LU1291159041.SGD","IE0004445239.USD","LU0265550359.USD","LLY","IE00BJT1NW94.SGD","LU0238689110.USD","LU1066051811.HKD","LU0471298694.HKD","LU1023059063.AUD","IE00BLSP4452.SGD","IE00BN8TJ469.HKD","LU0122379950.USD","LU1037948897.HKD","LU1057294990.SGD","LU1585245621.USD","LU0289739699.SGD","LU1989771016.USD","LU1280957306.USD","LU1934455194.USD","LU1989772840.SGD","LU0208291251.USD","LU0417517546.SGD","IE00BJLML261.HKD","LU0058720904.USD","LU1037948541.HKD","MRK","LU1035775433.USD","LU0234572021.USD","LU0965509283.SGD","IE00B1BXHZ80.USD","LU0965509101.SGD","IE00BSNM7G36.USD","LU1941712348.USD"],"gpt_icon":0},{"id":"2450580600","title":"尚未走出默沙东的阴影，万泰生物业绩继续下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2450580600","media":"华尔街见闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450580600?lang=zh_cn&edition=full","pubTime":"2024-07-11 11:57","pubTimestamp":1720670239,"startTime":"0","endTime":"0","summary":"何时见曙光","market":"us","thumbnail":"https://wpimg-wscn.awtmt.com/b57af0fc-9fbf-491c-92df-b25a535e11dd.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/b57af0fc-9fbf-491c-92df-b25a535e11dd.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3719315","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3719315","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["LU0289739699.SGD","LU1037948897.HKD","LU0965509010.AUD","LU1116320901.HKD","IE00BLSP4239.USD","LU0234572021.USD","LU0965509101.SGD","LU1430594728.SGD","LU1974910355.USD","LU1057294990.SGD","BK4585","LU1941712348.USD","IE0009355771.USD","IE00BLSP4452.SGD","BK4588","LU1585245621.USD","LU1941712264.USD","LU0265550946.USD","LU0320765489.SGD","09633","IE00BN8TJ469.HKD","LU1066053197.SGD","LU1023059063.AUD","LU1116320737.USD","LU0985320562.USD","MRK","LU0965508806.USD","BK1200","IE00BBT3K403.USD","LU1093756168.USD","IE00BJT1NW94.SGD","LU1981816686.USD","LU0070302665.USD","LU0208291251.USD","LU0861579265.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU1934455277.USD","LU1989771016.USD","IE00B1BXHZ80.USD","LU0965509283.SGD","IE00BSNM7G36.USD","LU0238689110.USD","LU1917777945.USD","LU1066051811.HKD","LU0266013472.USD","LU1934455194.USD","LU1291159041.SGD","IE00B4R5TH58.HKD","LU1037948541.HKD"],"gpt_icon":0},{"id":"2450204225","title":"Prelude Therapeutics(PRLD.US)一度暴涨28%！与默沙东(MRK.US)达成临床试验合作和供应协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2450204225","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450204225?lang=zh_cn&edition=full","pubTime":"2024-07-09 21:00","pubTimestamp":1720530028,"startTime":"0","endTime":"0","summary":"智通财经获悉，近日，Prelude Therapeutics与默沙东达成临床试验合作与供应协议。根据协议条款，2期临床研究将评估Prelude Therapeutics旗下疗法PRT3789与默沙东的抗PD-1肿瘤免疫疗法KEYTRUDA联合治疗SMARCA4突变癌症患者的效果。Prelude Therapeutics和默沙东将各自保留各自疗法的所有商业权利，包括作为单一疗法或联合疗法。消息传出后，Prelude Therapeutics一度飙涨28%；截至发稿，该公司股价周二盘前回落，微跌0.2%。PRT3789是一种高选择性、一流的SMARCA2降解剂，目前在生物标志物选择的SMARCA4突变患者中处于1期临床开发阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1148201.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1066051498.USD","LU2023250843.SGD","IE00BLSP4239.USD","SG9999014559.SGD","LU0122379950.USD","IE0009355771.USD","LU1093756325.SGD","IE00BJJMRZ35.SGD","BK4505","SG9999014567.USD","BK1576","BK4534","SG9999001176.SGD","BK1583","LU2361044865.SGD","IE00B1BXHZ80.USD","LU2468319806.SGD","03347","BK4588","BK4559","LU0289739699.SGD","LU1989772840.SGD","LU2461242641.AUD","LU2023250504.SGD","SG9999001176.USD","LU0211331839.USD","LU1585245621.USD","LU1989771016.USD","SG9999013999.USD","LU1057294990.SGD","LU0965509283.SGD","LU0208291251.USD","LU2361044949.HKD","IE0002141913.USD","LU1023059063.AUD","BK4533","LU2361045086.USD","LENZ","PRLD","BK4007","LU1917777945.USD","LU1989772923.USD","LU1066053197.SGD","IE00BBT3K403.USD","LU0058720904.USD","BK1141","IE00BJT1NW94.SGD","LU1093756168.USD","MRK","SG9999014542.SGD"],"gpt_icon":0},{"id":"2450021043","title":"Prelude Therapeutics与默沙东开展临床合作，评估PRT3789与KEYTRUDA的联用效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2450021043","media":"界面","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450021043?lang=zh_cn&edition=full","pubTime":"2024-07-09 19:40","pubTimestamp":1720525243,"startTime":"0","endTime":"0","summary":"7月9日，临床阶段的精准肿瘤学公司Prelude Therapeutics宣布与默沙东公司签署了一项临床试验合作与供应协议。根据协议条款，2期临床研究将评估PRT3789与默沙东公司的抗PD-1肿瘤免疫疗法KEYTRUDA联合治疗SMARCA4突变癌症患者的效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709194043af915345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709194043af915345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0234572021.USD","IE00BFTCPJ56.SGD","LU0985320562.USD","LU0965509283.SGD","LU1974910355.USD","MRK","BK4585","SG9999002224.SGD","BK4559","SG9999001440.SGD","LU0861579265.USD","LU1291159041.SGD","BK4505","IE00BLSP4239.USD","LU0965509010.AUD","LU0238689110.USD","LU2106854487.HKD","SG9999002232.USD","IE00BLSP4452.SGD","IE00BSNM7G36.USD","LU0070302665.USD","LU1917777945.USD","SG9999013999.USD","LENZ","PRLD","IE0009355771.USD","SG9999014559.SGD","BK4588","IE00BJT1NW94.SGD","LU0289739699.SGD","LU0320765489.SGD","LU1430594728.SGD","LU1585245621.USD","LU1057294990.SGD","LU2461242641.AUD","LU2468319806.SGD","LU1023059063.AUD","IE00B2B36J28.USD","LU1066053197.SGD","SG9999014567.USD","LU0965509101.SGD","BK4550","LU2023250504.SGD","LU0208291251.USD","BK4139","LU1093756168.USD","SG9999014542.SGD","BK4516","LU0266013472.USD","LU2023250843.SGD"],"gpt_icon":0},{"id":"2449325696","title":"国产四价HPV疫苗上市申请获受理 留给默沙东的时间不多了","url":"https://stock-news.laohu8.com/highlight/detail?id=2449325696","media":"新京报网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449325696?lang=zh_cn&edition=full","pubTime":"2024-07-05 16:58","pubTimestamp":1720169880,"startTime":"0","endTime":"0","summary":"7月4日，国药集团旗下成都生物制品研究所四价HPV疫苗上市申请获得国家药监局受理，有望打破外企默沙东独享国内市场的局面。国内获批的HPV疫苗目前包括二价、四价和九价三种，其中四价和九价HPV疫苗市场由默沙东独占。九价HPV疫苗市场预计2025年后迎来多位竞争对手不过，留给默沙东的时间不多了。目前国内尚未将HPV疫苗纳入免疫规划，市场增长速度和空间规模势必会受到影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705170007aef81faa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705170007aef81faa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0058720904.USD","LU0211331839.USD","IE00BBT3K403.USD","LU2023250504.SGD","LU0122379950.USD","LU2361045086.USD","BK4534","IE00B1BXHZ80.USD","LU1989771016.USD","LU1066051498.USD","BK4585","SG9999002232.USD","LU0861579265.USD","IE00BJT1NW94.SGD","LU1093756325.SGD","LU2468319806.SGD","LU0965509283.SGD","IE00B2B36J28.USD","BK4559","IE0002141913.USD","SG9999014559.SGD","LU0070302665.USD","LU2461242641.AUD","LU1023059063.AUD","BK4588","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4533","LU1066053197.SGD","BK4550","LU1057294990.SGD","LU2361044865.SGD","LU1989772840.SGD","SG9999014567.USD","SG9999001176.USD","LU0985320562.USD","MRK","IE0009355771.USD","BK4516","LU0320765489.SGD","LU1989772923.USD","LU2361044949.HKD","LU1974910355.USD","LU1093756168.USD","SG9999001176.SGD","IE00BLSP4239.USD","SG9999002224.SGD","LU1917777945.USD","BK4007","LU1430594728.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.merck.com","stockEarnings":[{"period":"1week","weight":-0.0156},{"period":"1month","weight":-0.0173},{"period":"3month","weight":-0.0001},{"period":"6month","weight":0.0579},{"period":"1year","weight":0.1596},{"period":"ytd","weight":0.1536}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司，通过其处方药提供创新的健康解决方案，包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理，包括两个经营分部：制药及动物保健国际。","yearOnYearQuotes":[{"month":1,"riseRate":0.568182,"avgChangeRate":0.009892},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.000396},{"month":3,"riseRate":0.636364,"avgChangeRate":-0.002321},{"month":4,"riseRate":0.622222,"avgChangeRate":0.018595},{"month":5,"riseRate":0.644444,"avgChangeRate":0.018719},{"month":6,"riseRate":0.511111,"avgChangeRate":0.01265},{"month":7,"riseRate":0.511111,"avgChangeRate":0.005712},{"month":8,"riseRate":0.477273,"avgChangeRate":0.000646},{"month":9,"riseRate":0.545455,"avgChangeRate":-0.005533},{"month":10,"riseRate":0.545455,"avgChangeRate":0.021263},{"month":11,"riseRate":0.727273,"avgChangeRate":0.029373},{"month":12,"riseRate":0.613636,"avgChangeRate":0.014794}],"exchange":"NYSE","name":"默沙东","nameEN":"Merck"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"默沙东,MRK,默沙东股票,默沙东股票老虎,默沙东股票老虎国际,默沙东行情,默沙东股票行情,默沙东股价,默沙东股市,默沙东股票价格,默沙东股票交易,默沙东股票购买,默沙东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}